A New Paradigm for the Utilization of Genomic Classifiers for Patient Selection in the Critical Path of Medical Product Development Richard Simon, D.Sc.
FDA-Industry-Biomarkers.ppt
Validation of Predictive Classifiers Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute .
Validation of Predictive Classifiers
Using Predictive Classifiers in the Design of Phase III Clinical Trials Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute.
Developing Predictive Classifiers and their Use in the Design of Pivotal Clinical Trials
Using Predictive Classifiers in the Design of Phase III Clinical Trials
Targeted (Enrichment) Design
When is Small Beautiful?
